Strain preservation of experimental animals: Vitrification of two-cell stage embryos for multiple mouse strains  by Eto, Tomoo et al.
Cryobiology 70 (2015) 150–155Contents lists available at ScienceDirect
Cryobiology
journal homepage: www.elsevier .com/ locate/ycryoStrain preservation of experimental animals: Vitriﬁcation of two-cell
stage embryos for multiple mouse strainsqhttp://dx.doi.org/10.1016/j.cryobiol.2015.01.008
0011-2240/ 2015 The Authors. Published by Elsevier Inc.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
q Statement of funding: This study was partially funded by Grant-in Aid for
Scientiﬁc Research on Priority Areas from the Japanese Ministry of Education,
Culture, Sports, Science, and Technology.
⇑ Corresponding author.
E-mail address: etoh@ciea.or.jp (T. Eto).Tomoo Eto ⇑, Riichi Takahashi, Tsutomu Kamisako
Central Institute for Experimental Animals, 3-25-12 Tonomachi, Kawasaki-ku, Kawasaki 210-0821, Japan
a r t i c l e i n f o a b s t r a c tArticle history:
Received 8 October 2014
Accepted 27 January 2015
Available online 4 February 2015
Keywords:
Strain preservation
Cryopreservation
Vitriﬁcation
Cryoprotectant solution
P10
PEPeS
Mouse
Mouse embryos
Multiple mouse strains
Two-cell stage embryosStrain preservation of experimental animals is crucial for experimental reproducibility. Maintaining com-
plete animal strains, however, is costly and there is a risk for genetic mutations as well as complete loss
due to disasters or illness. Therefore, the development of effective vitriﬁcation techniques for cryopres-
ervation of multiple experimental animal strains is important. We examined whether a vitriﬁcation
method using cryoprotectant solutions, P10 and PEPeS, is suitable for preservation of multiple inbred
and outbred mouse strains. First, we investigated whether our vitriﬁcation method using cryoprotectant
solutions was suitable for two-cell stage mouse embryos. In vitro development of embryos exposed to the
cryoprotectant solutions was similar to that of fresh controls. Further, the survival rate of the vitriﬁed
embryos was extremely high (98.1%). Next, we collected and vitriﬁed two-cell stage embryos of 14 mouse
strains. The average number of embryos obtained from one female was 7.3–33.3. The survival rate of vit-
riﬁed embryos ranged from 92.8% to 99.1%, with no signiﬁcant differences among mouse strains. In vivo
development did not differ signiﬁcantly between fresh controls and vitriﬁed embryos of each strain. For
strain preservation using cryopreserved embryos, two offspring for inbred lines and one offspring for out-
bred lines must be produced from two-cell stage embryos collected from one female. The expected num-
ber of surviving fetuses obtained from embryos collected from one female of either the inbred or outbred
strains ranged from 2.9 to 19.5. The ﬁndings of the present study indicated that this vitriﬁcation method
is suitable for strain preservation of multiple mouse strains.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Mice are used as experimental animals in many ﬁelds, including
genetics, medicine, pharmacy, physiology, and biology [2,24,25],
and many inbred and outbred strains have been developed. The
development of DNA injection technology in the 1980s [10] fol-
lowed by gene targeting technology using embryonic stem cells
[4] led to a marked increase in the number of genetically modiﬁed
mouse strains. Genetically modiﬁed mice may be backcrossed with
mice of other genetic backgrounds to alter the phenotype [5].
Maintaining complete strains of mice, the number of which is con-
tinuously increasing, however, is costly [19]. In addition, there is a
risk of strain loss due to genetic mutations [15] and disasters [6].
Cryopreservation of early embryos is extremely effective for the
preservation of mouse strains [20]. Although several methods areavailable for cryopreservation of early mouse embryos, including
freezing [35] and vitriﬁcation [28], the survival rate of early
embryos after cryopreservation tends to be higher for the vitriﬁca-
tion technique with little difference among strains [18] compared
to freezing [29–31,34]. Embryo development of multiple strains
after cryopreservation also tends to be better with vitriﬁcation
than with freezing [7]. For vitriﬁcation of early embryos, it is nec-
essary to apply cryoprotectant solution (CPS) and a vitriﬁcation
technique with high freezing tolerance, low cytotoxicity, preven-
tion of cellular expansion after warming, and no induction of freeze
fractures in the vitriﬁcation solution [17].
We previously developed a vitriﬁcation method with CPS (P10
and PEPeS) that fulﬁlls these criteria [9]. The vitriﬁcation method
used in this study, however, was designed for rat two-cell stage
embryos. In the present study, we investigated whether this vitri-
ﬁcation method could be applied for the cryopreservation of two-
cell stage embryos of multiple mouse strains. In Experiment 1, we
evaluated whether vitriﬁcation is suitable for two-cell-stage
mouse embryos. In Experiment 2, we examined the efﬁcacy of
strain preservation using this method for two-cell stage embryos
of 14 mouse strains.
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Animals
Mouse embryos from 14 strains were used (males 12–16 weeks
old and females 8–16 weeks old). Inbred C57BL/10ScN, CBA/N,
NOD/Shi, TWY/Jic-ttw, and NOD/Shi-scid mice were obtained from
the Central Institute for Experimental Animals (Kawasaki, Japan).
Inbred C57BL/6J, C57BL/6N, BALB/cA, BALB/cByJ, DBA/2J, C3H/HeJ,
and 129+Tar/Sv mice, and outbred ICR mice were obtained from
CLEA Japan, Inc. (Tokyo, Japan). Inbred C57BL/6NCr mice were
obtained from Japan SLC, Inc. (Shizuoka, Japan). For embryo trans-
fer, pseudopregnant female Jcl:MCH(ICR) strain mice, 10–16 weeks
old (CLEA Japan), were produced by breeding them with vasecto-
mized male mice of the same strain. The mice were reared under
the following conditions: room temperature, 22 C ± 0.5 C;
humidity, 55% ± 5%; lights on 08:00–20:00. Food (CA-1; CLEA Japan
Inc.) and water were provided ad libitum. The rearing of the mice
and the animal experiments were conducted according to the insti-
tutional rules following approval from the Animal Experiment
Committee of Central Institute for Experimental Animals in Japan.Collection, in vitro culture, and in vivo development of two-cell stage
embryos
In this experiment, two-cell stage embryos were used. Female
mice were injected intra-abdominally with 5IU equine chorionic
gonadotropin (Serotropin; ASUKA Pharmaceutical Co., Ltd., Tokyo,
Japan), followed by intra-abdominal injection of 5IU human chori-
onic gonadotropin (Gonadotropin; ASUKA Pharmaceutical Co., Ltd.)
50 h later (17:00–19:00) to induce excessive ovulation. Two-cell
stage embryos of BALB/cA, BALB/cByJ, CBA/N, and ICR mice were
collected by oviduct ﬂushing after natural mating. Two-cell stage
embryos of the other strains were obtained by in vitro fertilization
(IVF). We used modiﬁed Whitten’s medium (mWM) for oviduct
ﬂushing and in vitro culture (IVC) of embryos [12,23]. In IVF, we
used a modiﬁed human tubal ﬂuid (mHTF) in which the calcium
concentration was doubled [27]. All reagents used to make the
media were purchased from Sigma–Aldrich Chemical Co. (St. Louis,
MO). The media were added to Petri dishes (351008; Becton Dickin-
son & Co., Franklin Lakes, NJ) in a dropwise manner (mHTF, 200 lL;
mWM, 50 lL) and then covered with mineral oil (26117-45; Nacalai
Tesque, Kyoto, Japan). IVF and IVC were performed in an atmo-
sphere of 5% CO2 and 95% air at 37 C. Oviduct ﬂushing was con-
ducted according to the method of Horgan et al. [13]. Immediately
after administering gonadotropin to female mice, they were mated
with males of the same strain. On day 1.5 after mating, the female
mice were euthanized by cervical dislocation for collection of two-
cell stage embryos. IVF was performed using a modiﬁed method
of Toyoda et al. [32,33]. Sperm were collected from the cauda epi-
didymis and preincubated for 1.5 h with mHTF. Approximately
16 h after administering gonadotropin to female mice, mHTF con-
taining oocytes was inseminated with the preincubated sperm
(100–150 sperm/lL). Approximately 6 h after insemination, the fer-
tilized ova were washed with mWM and IVC was performed with
embryos at the two-cell stage or less. The embryos were transferred
to the oviducts of pseudopregnant female mice on day 0.5 after mat-
ing for examination of in vivo development [14]. Pseudopregnant
mice were euthanized on days 17.5–8.5 after embryo transfer and
a laparotomy was performed to observe embryo development.Fig. 1. Cryopreserved C57BL/6J strain 2-cell stage embryos after warming. The
arrows show embryos that degenerated.Experiment 1
Cryopreservation of the two-cell stage embryos was performed
according to the method of Eto et al. [9]. The solution used forvitriﬁcation and warming was prepared by adding cryoprotectant
to PB1 [35]. Vitriﬁcation was performed with a pre-treatment solu-
tion (P10; 10% propylene glycol in PB1) and vitriﬁcation solution
(PEPeS; 10% propylene glycol, 30% ethylene glycol, 0.3 M sucrose,
and 20% Percoll in PB1). SPB1 (0.3 M sucrose in PB1) was used to
warm the vitriﬁed embryos. Percoll was obtained from GE Health-
care (Uppsala, Sweden), and other reagents for preparing the solu-
tions were purchased from Sigma–Aldrich Chemical Co. Two-cell
stage embryos of the C57BL/6J strain were used in the
experiments.
The methods for vitriﬁcation and warming of embryos were as
follows. The embryos were exposed to P10 at 25 ± 0.5 C for 5 min.
The embryos and 5 lL of P10 were then placed into cryotubes (MS-
4501W; Sumitomo Bakelite Co., Ltd., Tokyo, Japan) and cooled to
0 C for 1 min. We then added 95 lL of precooled (0 C) vitriﬁca-
tion solution to the cryotubes, and 1 min later the cryotubes were
plunged into liquid nitrogen for vitriﬁcation. The vitriﬁed two-cell
stage embryos were stored in liquid nitrogen for at least 1 week.
The vitriﬁed embryos were warmed by shifting the cryotubes
from liquid nitrogen to room temperature (25 ± 0.5 C). Thirty sec-
onds later, 900 lL of SPB1 at 37 C was added to the cryotubes and
the mixture was rapidly stirred 5–6 times. The warmed embryos
were placed in PB1 after the addition of SPB1, left undisturbed
for 2 min, washed three times with PB1, washed three times with
mWM, and then used for IVC.
In this experiment, after the two-cell stage embryos were
exposed to the CPS, SPB1 was infused into the cryotubes. The
two-cell stage embryos were collected by the same method used
for the warming procedures.
The survival rates of the vitriﬁed embryos and fresh embryos
exposed to CPS were evaluated under an inverted microscope
(OLYMPUS IX70, magniﬁcation 200) after placing the embryos
in mWM (Fig. 1). The surviving two-cell-stage embryos underwent
IVC for 72 h and development to blastocysts was examined. As a
fresh control group, untreated embryos were also subjected to IVC.Experiment 2
The two-cell stage embryos used in the experiments were col-
lected using the IVF method or oviduct ﬂushing method. Two-cell
stage embryos of 14 mouse strains were subjected to vitriﬁcation
using the same method as described in Experiment 1, and the
152 T. Eto et al. / Cryobiology 70 (2015) 150–155survival rates of the embryos after warming were evaluated. After
warming, the surviving embryos were examined for in vivo
development.
Statistical analysis
The experimental results shown in survival rates and develop-
ment of two-cell stage embryos are expressed as means ± standard
error of mean (SEM), and those in other tables are expressed as
means. Statistical analysis was conducted with the Student’s t-test
after checking normal distribution. In all analyses, P < 0.01 was
considered to indicate statistical signiﬁcance. For analyses of the
experimental data, Statcel3 (OMS Publishing, Saitama, Japan),
automated analysis software, was used.
Results
In Experiment 1, none of the embryos died, even after exposure
of the two-cell stage embryos to CPS (Table 1). There were no sig-
niﬁcant differences in development to blastocysts in IVC between
CPS-exposed embryos (89.9%, 107/109) and fresh embryos
(93.3%, 84/90). The survival rate of the vitriﬁed two-cell stage
embryos was 98.1% (155/158), which was not signiﬁcantly differ-
ent from that of vitriﬁed two-cell stage embryos exposed to CPS
(P > 0.01). The rate of development to blastocysts in IVC was not
signiﬁcantly different between the vitriﬁed embryos (93.5%, 145/
155) and those exposed to CPS or fresh embryos.
In Experiment 2, collection, vitriﬁcation, and in vivo develop-
ment were evaluated in two-cell stage embryos of 14 mouse
strains. The fertilization rate (number of two-cell stage embryos/
number of embryos examined) was as follows: C57BL/6J 83.2%
(830/998); C57BL/6N 95.5% (318/333); C57BL/6NCr 97.3% (253/
260); BALB/cA 92.9% (338/364); BALB/cByJ 75.2% (513/682); C3H/Table 1
Effect of cryoprotectant solution in vitriﬁcation of two-cell stage mouse embryos.
Treatment Survival of embryos after treated
No. of embryos recovered/
treated (% ± SEM)*
No. of emb
recovered (
Fresh control – –
Exposure to cryoprotectant solution 199/200 (99.2 ± 0.8) 199/199 (1
Vitriﬁcation 158/160 (98.8 ± 1.3) 155/158 (9
* There were no signiﬁcant differences among any groups (P > 0.01).
Table 2
Collection of two-cell stage embryos of multiple mouse strains.
Mouse strain Classiﬁcation of genetic
background
Method of embryo
collection*
Number of fema
embryo collecte
C57BL/6J Inbred IVF 50
C57BL/6N Inbred IVF 23
C57BL/6NCr Inbred IVF 10
BALB/cA Inbred OF 20
BALB/cByJ Inbred OF 26
C3H/HeJ Inbred IVF 31
CBA/N Inbred OF 16
DBA/2J Inbred IVF 41
C57BL/10ScN Inbred IVF 22
129+Tar/Sv Inbred OF 16
NOD/Shi Inbred IVF 43
NOD/Shi-scid Inbred IVF 51
TWY/Jic-ttw Inbred IVF 68
ICR Outbred OF 23
* IVF; in vitro fertilization, OF; oviduct ﬂushing of after natural mating.
** Number of two-cell stage embryos obtained/combined number of unfertilized oocyt
*** Number of two-cell stage embryos obtained/number of females embryo collected.HeJ 94.1% (459/488); CBA/N 97.3% (532/547); DBA/2J 48.5% (300/
619); C57BL/10ScN 97.5% (349/358); 129+Tar/Sv 64.8% (311/480);
NOD/Shi 96.3% (1262/1310); NOD/Shi-scid 96.6% (889/920);
TWY/Jic-ttw 80.7% (1388/1720); and ICR 96.1% (518/539) (Table 2).
DBA/2J showed a reduced fertilization rate, ranging from 26.7% to
48.1%, compared to other strains, and average collection of two-cell
stage embryos dropped from 52.9% to 21.9% compared to the other
strains. The average numbers of two-cell stage embryos collected
were 16.6, 13.8, 25.3, 16.9, 19.7, 14.8, 33.3, 7.3, 15.9, 19.4, 29.3,
17.4, 20.4, and 22.5 for C57BL/6J, C57BL/6N, C57BL/6NCr, BALB/
cA, BALB/cByJ, C3H/HeJ, CBA/N, DBA/2J, C57BL/10ScN, 129+Tar/Sv,
NOD/Shi, NOD/Shi-scid, TWY/Jic-ttw, and ICR, respectively (total
number of embryos obtained/number of females from which
embryos were collected).
The survival rates (number of embryos survived/number of
embryos recovered) of vitriﬁed embryos were as follows: C57BL/
6J 99.1% (329/332); C57BL/6N 97.5% (195/200); C57BL/6NCr
97.1% (169/174); BALB/cA 96.2% (150/156); BALB/cByJ 98.4%
(241/245); C3H/HeJ 96.7% (115/119); CBA/N 94.1% (238/253);
DBA/2J 95.0% (114/120); C57BL/10ScN 96.7% (171/177); 129+Tar/
Sv 99.2% (129/130); NOD/Shi 92.5% (111/120); NOD/Shi-scid
95.0% (114/120); TWY/Jic-ttw 93.2% (165/177); and ICR 92.8%
(142/153); and the differences among strains were not signiﬁcant
(P > 0.01; Table 3).
The fetus development rates (number of fetuses/number of
embryos transferred) of the fresh embryos and the vitriﬁed
embryos, respectively, were as follows: C57BL/6J 60.0% (60/100)
and 61.3% (98/160); C57BL/6N 54.8% (91/166) and 47.9% (67/
140); C57BL/6NCr 66.7% (40/60) and 60.8% (79/130); BALB/cA
39.4% (67/120) and 31.8% (60/137); BALB/cByJ 38.3% (46/162)
and 31.4% (43/194); C3H/HeJ 52.2% (83/159) and 46.4% (51/110);
CBA/N 67.9% (91/134) and 63.3% (69/109); DBA/2J 52.2% (60/115)
and 42.2% (46/109); C57BL/10ScN 60.0% (72/120) and 56.4%In vitro development to the blastocyst
ryos survived/
% ± SEM)*
Frequency of
experiment
No. of blastocyst/
cultured (% ± SEM)*
Frequency of
experiment
– 84/90 (93.3 ± 1.7) 12
00 ± 0.0) 4 107/119 (89.9 ± 2.1) 12
8.1 ± 1.9) 4 145/155 (93.5 ± 2.0) 16
les
d
Number of two-cell stage
embryos obtained
Rate of
fertilized (%)**
Number of collected
two-cell stage embryos
per female***
830 83.2 16.6
318 95.5 13.8
253 97.3 25.3
338 92.9 16.9
513 75.2 19.7
459 94.1 14.8
532 97.3 33.3
300 48.5 7.3
349 97.5 15.9
311 64.8 19.4
1262 96.3 29.3
889 96.6 17.4
1388 80.7 20.4
518 96.1 22.5
es and two-cell stage embryos.
Table 3
Survival of vitriﬁed two-cell stage embryos of multiple mouse strains.
Mouse strain No. of embryos recovered/vitriﬁed (% ± SEM)* No. of embryos survived/recovered (% ± SEM)* Frequency of experiment
C57BL/6J 332/336 (98.8 ± 0.6) 329/332 (99.1 ± 0.6) 12
C57BL/6N 200/204 (98.0 ± 1.2) 195/200 (97.5 ± 1.7) 4
C57BL/6NCr 174/174 (100 ± 0) 169/174 (97.1 ± 0.6) 3
BALB/cA 156/156 (100 ± 0) 150/156 (96.2 ± 1.5) 4
BALB/cByJ 245/246 (99.6 ± 0.3) 241/245 (98.4 ± 0.8) 6
C3H/HeJ 119/119 (100 ± 0) 115/119 (96.7 ± 2.8) 3
CBA/N 253/257 (98.4 ± 0.7) 238/253 (94.1 ± 2.1) 6
DBA/2J 120/121 (99.2 ± 0.7) 114/120 (95.0 ± 5.5) 4
C57BL/10ScN 177/178 (99.4 ± 0.7) 171/177 (96.7 ± 1.7) 3
129+Tar/Sv 130/130 (100 ± 0) 129/130 (99.2 ± 0.6) 4
NOD/Shi 120/120 (100 ± 0) 111/120 (92.5 ± 3.8) 3
NOD/Shi-scid 120/120 (100 ± 0) 114/120 (95.0 ± 5.0) 3
TWY/Jic-ttw 177/177 (100 ± 0) 165/177 (93.2 ± 5.1) 3
ICR 153/157 (97.3 ± 1.5) 142/153 (92.8 ± 3.9) 3
* There were no signiﬁcant differences among any groups (P > 0.01).
Table 4
In vivo development of vitriﬁed two-cell stage embryos of multiple mouse strains.
Mouse strain Treatment No. of implantation/transferred (% ± SEM)* No. of fetuses/transferred (% ± SEM)* Frequency of experiment
C57BL/6J Vitriﬁcation 143/160 (89.4 ± 4.4) 98/160 (61.3 ± 4.7) 16
Fresh 82/100 (82.0 ± 4.9) 60/100 (60.0 ± 6.0) 10
C57BL/6N Vitriﬁcation 113/140 (80.7 ± 3.2) 67/140 (47.9 ± 5.0) 14
Fresh 137/166 (82.5 ± 4.4) 91/166 (54.8 ± 3.8) 17
C57BL/6NCr Vitriﬁcation 104/130 (80.0 ± 5.6) 79/130 (60.8 ± 5.5) 14
Fresh 46/60 (76.7 ± 14.1) 40/60 (66.7 ± 12.3) 6
BALB/cA Vitriﬁcation 94/137 (69.1 ± 3.7) 60/137 (31.8 ± 3.2) 15
Fresh 93/120 (77.8 ± 3.0) 67/120 (39.4 ± 3.1) 14
BALB/cByJ Vitriﬁcation 113/194 (59.0 ± 4.2) 43/194 (31.4 ± 3.7) 23
Fresh 100/162 (61.7 ± 4.9) 46/162 (38.3 ± 4.7) 18
C3H/HeJ Vitriﬁcation 81/110 (73.6 ± 6.5) 51/110 (46.4 ± 6.3) 12
Fresh 122/159 (76.7 ± 5.9) 83/159 (52.2 ± 5.2) 18
CBA/N Vitriﬁcation 76/109 (69.7 ± 6.9) 69/109 (63.3 ± 6.8) 12
Fresh 100/134 (74.6 ± 5.4) 91/134 (67.9 ± 4.6) 14
DBA/2J Vitriﬁcation 75/109 (68.8 ± 4.3) 46/109 (42.2 ± 3.9) 14
Fresh 88/115 (76.5 ± 5.3) 60/115 (52.2 ± 5.7) 14
C57BL/10ScN Vitriﬁcation 113/149 (75.8 ± 6.6) 113/149 (56.4 ± 4.9) 10
Fresh 91/120 (75.8 ± 5.1) 72/120 (60.0 ± 5.9) 12
129+Tar/Sv Vitriﬁcation 85/129 (65.9 ± 7.4) 81/129 (62.8 ± 7.2) 14
Fresh 66/91 (72.5 ± 8.5) 59/91 (64.8 ± 8.8) 10
NOD/Shi Vitriﬁcation 94/111 (84.7 ± 3.8) 58/111 (50.9 ± 4.2) 12
Fresh 115/140 (82.1 ± 6.2) 67/140 (60.9 ± 6.6) 14
NOD/Shi-scid Vitriﬁcation 85/114 (74.6 ± 5.6) 59/114 (60.8 ± 5.9) 12
Fresh 94/110 (85.5 ± 2.1) 76/110 (63.9 ± 3.4) 11
TWY/Jic-ttw Vitriﬁcation 69/97 (71.1 ± 6.7) 67/97 (60.4 ± 6.0) 10
Fresh 96/119 (80.7 ± 6.7) 100/119 (71.4 ± 6.5) 12
ICR Vitriﬁcation 95/118 (80.5 ± 5.2) 88/118 (74.6 ± 4.8) 14
Fresh 86/100 (86.0 ± 4.8) 81/100 (81.0 ± 5.9) 10
* There were no signiﬁcant differences among fresh and vitriﬁcation groups of same strains (P > 0.01).
T. Eto et al. / Cryobiology 70 (2015) 150–155 153(113/149); 129+Tar/Sv 64.8% (59/91) and 62.8% (81/129); NOD/Shi
60.9% (67/140) and 50.9% (58/111); NOD/Shi-scid 63.9% (76/110)
and 60.8% (59/114); TWY/Jic-ttw 71.4% (100/119) and 60.5% (67/
97); and ICR 81.0% (81/100) and 74.6% (88/118). There were no sig-
niﬁcant differences between vitriﬁed and fresh embryos in each
strain (P > 0.01; Table 4).
Discussion
Early embryos exposed to CPS may die due to cytotoxicity of the
cryoprotectant, depending on the type and concentration of the
agents added to the CPS [21]. In Experiment 1, however, the cyto-
toxic effects of the CPS (P10 and PEPeS) used for vitriﬁcation of
two-cell stage mouse embryos were low (Table 1). The survival
rate of 2-cell stage embryos after vitriﬁcation was high and stable
(98.1 ± 1.9, Table 1). Propylene glycol added to the CPS enhances
the permeation of the cryoprotectant into two-cell stage mouse
embryos better than other cell-permeable cryoprotectants [26].Presumably, freezing tolerance of the embryo was increased by
the enhanced permeability of the rapid intracellular propylene gly-
col. To prevent rapid cell expansion after warming, sucrose was
added to PEPeS and SPB1 [9], thus embryo damage due to shock
by osmotic pressure was decreased [8]. Depending on the CPS or
cooling conditions, freeze fractures may occur in CPS, which could
damage the embryos [16]. PEPeS, however, inhibits the occurrence
of freeze fractures due to the effect of Percoll [9]. Therefore,
destruction of the embryos by freeze fractures is extremely low.
There was no signiﬁcant difference in the in vitro development rate
between the vitriﬁed embryos and fresh control. Therefore, mouse
2-cell stage embryos in CPS (P10 and PEPeS) are considered to have
adequate freezing tolerance. Based on the ﬁndings of Experiment 1,
our vitriﬁcation method is suitable for cryopreservation of two-cell
stage mouse embryos.
There are some reports of signiﬁcant differences between
strains in the survival rate of cryopreserved embryos using the fro-
zen method [31,34]. In Experiment 2, the survival rates for the
Table 5
Expected value for number of live fetuses made from per female used in embryo collection.
Mouse strain Number of collected two-cell stage
embryos per femaleA*
Recovery rate of
vitriﬁed embryos (%)B*
Survival rate of
vitriﬁed embryos (%)C*
Developmental rate
of live fetuses (%)D*
Expected number of
live fetuses from per female**
C57BL/6J 16.6 98.8 99.1 61.3 10.0
C57BL/6N 13.8 98.0 97.5 47.9 6.3
C57BL/6NCr 25.3 100.0 97.1 60.8 14.9
BALB/cA 16.9 100.0 96.2 31.8 5.2
BALB/cByJ 19.7 99.6 98.4 31.4 6.1
C3H/HeJ 14.8 100.0 96.7 46.4 6.6
CBA/N 33.3 98.4 94.1 63.3 19.5
DBA/2J 7.3 99.2 95.0 42.2 2.9
C57BL/10ScN 15.9 99.4 96.7 56.4 8.6
129+Tar/Sv 19.4 100.0 99.2 62.8 12.1
NOD/Shi 29.3 100.0 92.5 50.9 13.8
NOD/Shi-scid 17.4 100.0 95.0 60.8 10.1
TWY/Jic-ttw 20.4 100.0 93.2 60.4 11.5
ICR 22.5 97.3 92.8 74.6 15.2
* Extracted from other table (A; Table 2, B and C; Table 3, D; Table 4).
** Results were calculated by the formula, expected number of live fetuses = A/B/C/D.
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99.4%, and there were no signiﬁcant differences between strains.
In addition, several studies report that the in vivo development
of cryopreserved embryos is signiﬁcantly lower than that of fresh
embryos [3,18]. In our experiments, however, there was no signif-
icant difference in the in vivo development between the cryopre-
served embryos and fresh embryos in all strains. The ﬁndings of
Experiment 2 suggested that our vitriﬁcation method is effective
for the cryopreservation of two-cell stage embryos of multiple
strains of mice.
For strain preservation using cryopreserved early embryos,
strain maintenance is achieved by producing a breeding pair using
offspring produced from cryopreserved embryos. Strain mainte-
nance of inbred strains is performed by sib mating [11]. Sib mating
is a method of passaging in which a breeding pair is produced from
the offspring born to one male/female pair. Therefore, strain pres-
ervation requires at least one male and one female offspring from
the two-cell stage embryos that have been cryopreserved after col-
lection from a single female. The results of the present study indi-
cate that strain preservation should be possible if the expected
number of fetuses produced from the cryopreserved embryos is
more than two. The expected number of surviving fetuses obtained
from the embryos collected from one female (average number of
two-cell stage embryos collected per female/collection rate of vit-
riﬁed embryos/survival rate of vitriﬁed embryos/embryo develop-
ment rate) for the inbred C57BL/6J, C57BL/6N, C57BL/6Cr, BALB/cA,
BALB/cByJ, C3H/HeJ, CBA/N, DBA/2J, C57BL/10ScN, 129+Tar/Sv,
NOD/Shi, NOD/Shi-scid, and TWY/Jic-ttw strains was 10.0, 6.3,
14.9, 5.2, 6.1, 6.6, 19.5, 2.9, 8.6, 12.1, 13.8. 10.1, and 11.5, respec-
tively (Table 5). In the case of outbred strains, passaging is per-
formed after multiple breeding pairs are produced and the
offspring of each breeding pair are mated randomly with those
from a different breeding pair [22]. Therefore, strain preservation
would be possible if one offspring is obtained from the embryos
that have been cryopreserved after collection from a single female
following the preparation of cryopreserved embryos from multiple
pairs. In the case of the ICR strain, which was the outbred strain
used in this experiment, the expected number of surviving fetuses
for the embryos collected from a single female was 15.1 (Table 5).
Our calculations suggested that breeding pairs can be prepared
from any strain, and strain maintenance can be restarted as two
or more offspring for inbred strains and one or more offspring for
outbred strains can be expected from the eggs collected from a sin-
gle female of all strains. Thus, the results of the present study sug-
gest that the vitriﬁcation method [9] for the two-cell stageembryos developed in our laboratory is effective for strain preser-
vation of multiple strains of mice.
Genetic modiﬁcations of existing strains are frequently carried
out [1], and the in vivo development rate of cryopreserved early
mouse embryos may decrease due to genetic background factors
[29,30]. This vitriﬁcation method, however, does not signiﬁcantly
decrease the in vivo development rate in multiple inbred or out-
bred strains. Therefore, our cryopreservation method will be a
powerful tool for strain preservation of genetically modiﬁed mouse
strains. The genetic backgrounds of the majority of experimental
animal mouse strains are produced by sib mating or random mat-
ing. If the genetic background is not managed, mouse strains can-
not be maintained. Our vitriﬁcation method is effective for
cryopreservation of experimental animal mouse strains. Additional
studies are needed, however, to further improve the preservation
of multiple mouse strains.
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